Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00876772
Recruitment Status : Unknown
Verified March 2011 by Charite University, Berlin, Germany.
Recruitment status was:  Recruiting
First Posted : April 7, 2009
Last Update Posted : March 24, 2011
Sponsor:
Information provided by:
Charite University, Berlin, Germany

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2012
Study Completion Date : No date given